![]() |
![]() |
![]() |
|
Vol. 8, No. 1-20, pp. 1-722 Jan. 7, 2009 - Oct. 21, 2009 A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
GENETIC INFORMATION NONDISCRIMINATION ACT (GINA)
– Ala. rules, In Brief, 532
– Clinical trial subjects protected against discrimination by employers and insurers, HHS issues guidance, 271 – Final rule expected from EEOC, 394; IRS, Labor Dep't, HHS issue interim rules, 663 – Ill. rules, In Brief, 532 – Nev. rules, In Brief, 532 – N.D. rules, In Brief, 532 – Survey calls for more protection from discrimination and false ads, 561 – Vt. rules, In Brief, 532 – Wyo. rules, In Brief, 532
– Antibiotic resistance, NIH guidelines at issue, 455
– Baylor, MD accuses IRB of not conducting proper investigation of claims about gene therapy experiments, remanded (S.D. Tex.), 11 – Biologics
See BIOLOGICS
– Commercial applications of gene sequencing data no breach of agreement (N.D. Ill.), 485 – Death in gene therapy trial confirmed, 486 – Direct-to-consumer genetic tests
– – False security raises concerns, 627
– – Federal oversight sought, 488 – – IVDs, tests likely to be considered, 626
– – EEOC proposes bias ban, 149; final rules expected, 370
– – GINA – – N.M. rules, In Brief, 497 – Egg donor compensation, N.Y. panel approves, 496 – Engineered organisms, USDA revising rules, seeks comments, 192 – Net operating loss carryover tax break, industry group want one-time refund, 45 – Patents
– – Breast and ovarian cancer gene patents challenged (S.D.N.Y.), 358
– – Effect on research
– – – Comments sought by HHS, 236
– – – Dire predictions not realized, journal reports, 236 – – Gene sequencing patents challenged (S.D.N.Y.), 580 – – Heart disease gene patent awarded, 151 – – Univ. of Utah human gene patents challenged (S.D.N.Y.), 513 – Recombinant DNA, NIH proposes expanded biosafety guidelines, 190 – Security at biosafety labs, GAO reports, 562 – Stanford accused of plagiarizing gene research, 484 – State developments
– – Ariz. plans virtual tissue bank, 160
– – Mich. creating biobank for newborns, 432 – Swiss biotech crop ban extended, 494 – Synthetic biology risks and benefits reviewed, 489 – Test results transmitted between health systems, 666 – Toxicogenomic data studied by EPA, 399 – Univ. of Wash. announces genome analysis strategy, 588 – Voluntary biotech quality management system, USDA launches pilot program to test, 83
– Governor announces medical innovation center, 401
– Stem cell research collaboration with Cal., In Brief, 677
– Bayh-Dole Act authority non-use, GAO reports, 522
– Clinical and Translational Science Awards announced by NIH, 526 – Closeout dates, HHS IG says CDC must observe, 165 – Coronary revascularization, NIH awards grants to study effectiveness, 708 – Financial conflicts, NIH may expand regulations, 357 – Fraud
– – Duke research grant administrative and clerical overcharges reported by HHS IG, 129
– – Fabricated audits sent to NIH, biotech firm director sentenced (W.D. Wash.), 375 – – Internal controls at NIH, HHS IG reports, 680 – – Omeros denies false claims charges (W.D. Wash.), 714 – – Weill Medical College settles grant fraud charges (S.D.N.Y.), 208 – – Yale settles false claims allegations over federal grants, 24 – Health informatics grants awarded by CDC, 671 – Management a top issue for HHS IG in 2009, 57 – Natl. Joint Replacement Registry, AHRQ awards grants, 527 – Orphan drug clinical trials, FDA grants to fund, 17 – Pediatric devices, In Brief, 675 – Recovery Act grants awarded by NIH, 649 – Small businesses
– – Cal. fair political practices agency issues warning, 54
– – New Jersey
– – – Brain injury research grants, In Brief, 402
– – – Cancer research grants, In Brief, 593 – – – Developmental disabilities research grants, In Brief, 593 – – – Spinal cord research, In Brief, 287; announced, In Brief, 712
See generally STEM CELL RESEARCH
– Univ. of R.I. gets NIH grant, 401 – Web application system, GAO reports, 520 – Web tool announced by NIH, 614 Contact the Webmaster at webmaster@bna.com Copyright © The Bureau of National Affairs, Inc. All Rights Reserved. |